Related Experiment Video

Updated: Jul 5, 2026

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

Guanosine promotes B16F10 melanoma cell differentiation through PKC-ERK 1/2 pathway

Katya Naliwaiko1, Aline C Luvizon, Lucélia Donatti

  • 1Department of Basic Pathology, Universidade Federal do Paraná, Curitiba, Brazil.

Chemico-Biological Interactions
|May 6, 2008
PubMed

Insights

Guanosine (Guo) promotes melanoma cell differentiation, reducing malignancy. This cytostatic effect, mediated by a PKC-ERK pathway, suggests Guo could enhance conventional therapies with lower toxicity.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Malignant melanoma presents a significant therapeutic challenge due to poor prognosis and treatment toxicity.
  • Novel therapeutic strategies are crucial for improving melanoma treatment effectiveness and reducing adverse effects.

Purpose of the Study:

  • To investigate the effects of Guanosine (Guo) on B16F10 melanoma cell differentiation and identify the underlying molecular mechanisms.
  • To explore the potential of Guo as a therapeutic agent for malignant melanoma.

Main Methods:

  • B16F10 melanoma cells were treated with Guanosine (Guo).
  • Cell differentiation markers (growth arrest, dendrite-like outgrowth, melanogenesis, motility) were assessed.
  • ERK 1/2 phosphorylation, intracellular cyclic AMP levels, and the involvement of Protein Kinase C (PKC) and Phospholipase C (PLC) were analyzed.
  • Comparisons were made with forskolin-induced differentiation.

Main Results:

  • Guanosine (Guo) induced B16F10 melanoma cell differentiation, characterized by growth arrest, dendrite-like outgrowth, increased melanogenesis, and reduced motility.
  • Sustained ERK 1/2 phosphorylation was observed, and its inhibition blocked dendrite formation.
  • The differentiation was independent of cyclic AMP but involved a Protein Kinase C (PKC)-ERK signaling axis.
  • Guanosine (Guo) demonstrated cytostatic rather than cytotoxic properties.

Conclusions:

  • Guanosine (Guo) acts as a differentiating agent in malignant melanoma, reducing cancer cell malignancy.
  • A novel cAMP-independent, PKC-ERK pathway mediates Guanosine (Guo)-induced melanoma cell differentiation.
  • Guanosine (Guo) holds promise for combination therapy with conventional anti-melanoma drugs to enhance efficacy and minimize toxicity.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: